Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
57.60
-4.05 (-6.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 67.5, with a low estimate of 60 and a high estimate of 75. The average target predicts an increase of 17.19% from the current stock price of 57.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | +30.21% | Feb 13, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | -13.19% | Nov 12, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | +4.17% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | -21.88% | Sep 18, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $30 → $45 | Strong Buy | Maintains | $30 → $45 | -21.88% | Aug 21, 2024 |
Financial Forecast
Revenue This Year
309.55M
from 247.65M
Increased by 25.00%
Revenue Next Year
354.13M
from 309.55M
Increased by 14.40%
EPS This Year
-2.06
from -10.50
EPS Next Year
1.27
from -2.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 320.1M | 376.0M | 419.4M |
| Avg | 309.6M | 354.1M | 392.8M |
| Low | 295.9M | 330.4M | 363.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 29.3% | 21.5% | 18.4% |
| Avg | 25.0% | 14.4% | 10.9% |
| Low | 19.5% | 6.7% | 2.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.88 | 2.24 | 3.47 |
| Avg | -2.06 | 1.27 | 2.14 |
| Low | -2.42 | 0.25 | 0.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 173.2% |
| Avg | - | - | 68.9% |
| Low | - | - | -30.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.